Clinical trial
Panitumumab in Combination With Irinotecan Chemotherapy as 2nd-line Therapy in…
NCT00475293 · Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD), Other · Completed
Key facts
| NCT number | NCT00475293 |
|---|---|
| Title | Panitumumab in Combination With Irinotecan Chemotherapy as 2nd-line Therapy in Subjects With mCRC |
| Official title | A Phase 2 Clinical Trial of Panitumumab in Combination With Irinotecan Chemotherapy as 2nd-line Therapy in Subjects With Metastatic Colorectal Cancer |
| Lead sponsor | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD), Other |
| Collaborators | Amgen Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Colorectal Cancer |
| Intervention type | Drug |
| Interventions | Panitumumab and CPT-11 |
| Enrollment | 85 |
| Start date | May 1, 2007 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | May 21, 2007 |
| Last update posted | Sep 13, 2013 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: